Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Global Animal Biotechnology Market Outlook 2024-2029 - Market Sees Increasing Prevalence of Obesity, Inflammation and Cancer in Dogs

      Research and Markets Logo

      News provided by

      Research and Markets

      Mar 21, 2024, 19:15 ET

      Share this article

      Share this article


      DUBLIN, March 21, 2024 /PRNewswire/ -- The "Animal Biotechnology Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.

      The animal biotechnology market is estimated to grow at a CAGR of 6.28% during the forecast period.

      Animals with enhanced growth rates, illness resistance, or the ability to synthesise therapeutic proteins have all been created via animal biotechnology. Animal biotechnology has advanced owing to recent advances in the sequencing of animal genomes, gene expression, and metabolic profiling of animal cells. Recent advancements in genome editing technologies, including TALENS, CRISPR-Cas, and Zinc Finger Nucleases, have opened up new possibilities for rapidly changing an animal's genetic composition to improve its health and well-being, agricultural productivity, and disease resistance.

      The growing demand for genetically engineered therapeutic proteins that offer improved disease resistance, their use in the treatment of cancer, and increased preventative care for animals are a few key growth drivers for the animal biotechnology market. Rising demand for the use of animals in agriculture, meat production, and animal-based products, rising public concern for the health and welfare of animals, an expanding role for animals in the creation of human pharmaceuticals, and an increase in animal adoption are all factors that contribute to the animal biotechnology market expansion.

      Increasing prevalence of obesity, inflammation and cancer in dogs

      The most prevalent nutritional problem in canines is obesity, and it has become more widespread in recent years which is a major driving factor for the animal biotechnology market expansion. Obesity is prevalent in dogs in several nations. Chronic low-grade inflammation is a common explanation for why obesity has so many detrimental effects on one's health. This is generally recognised and acknowledged, and multiple research shows a link between obesity and an increased risk of developing some malignancies and associated effects. These explanations are crucial since, like obesity, dog cancer incidence has grown recently, making it a substantial cause of death for these animals.

      Increasing government initiatives

      To improve India's preparedness and response to potential animal pandemics in line with the One Health approach, Union Minister for Fisheries, Animal Husbandry, and Dairy, Shri Parshottam Rupala, unveiled the Animal Pandemic Preparedness Initiative and the World Bank-funded Animal Health System Support for One Health. With an emphasis on zoonotic illnesses that are dangerous to both animal and human health, this effort seeks to improve India's readiness for and response to animal pandemics. Through community engagement, this effort works to increase farmer knowledge while also enhancing veterinarian services and infrastructure, disease surveillance capabilities, early detection and response, and the ability of animal health experts. 

      Increasing demand for vaccines

      The rising prevalence of animal illnesses is the major reason for the growth of vaccines in the animal biotechnology market. Close contact with diseased people or animals, or other natural means, these illnesses are naturally passed from animals to humans because of contaminated food and water intake. Furthermore, in June 2023, the introduction of NANDI (NOC Approval for New Drug and Inoculation System) showed that DAHD is making progress towards implementing the treatments outlined in its Animal Pandemic Preparedness Initiative (APPI). Furthermore, in July 2023, the Centre on Vaccine Evaluation and Alternatives for Antimicrobials, or CVEAA, officially opened at Kansas State University's College of Veterinary Medicine to assist the use and development of animal vaccines.

      In North America, it is projected that the animal biotechnology market will grow steadily.

      It is projected that the existence of healthcare programmes and a rise in the number of efforts to enhance animal health will increase this region's potential for animal biotechnology market growth. Additionally, it is projected that the region's strong R&D investment would accelerate animal biotechnology market expansion in North America. For instance, in May 2023, the National Institute of Standards and Technology (NIST) and the U.S. Food and Drug Administration jointly announced a project that aims to provide an important new resource for researchers and businesses developing novel animal biotechnology products by using genome editing to change the animals' genomes. The FDA is working on this initiative as part of its ongoing efforts to promote the development of safe, useful biotechnology products.

      Animal Biotechnology Products at CVM

      CVM is dedicated to advancing new technologies for the production of safe and reliable goods while preserving customer confidence via the use of a science- and risk-based regulatory framework. IGAs in animals and ACTPs are the two examples of novel animal products that CVM promotes and supports in their development.

      The Veterinary Innovation Programme (VIP), which offers more clarity in the regulatory process, promotes research and development, and supports an effective and predictable pathway to approval for ACTPs and IGAs in animals, was established by CVM to facilitate advancements in the development of novel animal products.

      Major Government Programs

      • One Health Initiative, the Department established a "One Health Centre" at the National Institute of Animal Biotechnology (NIAB), Hyderabad to foster cross-sectoral cooperation between the veterinary, medical, agricultural, environmental, forestry, meteorological, and other fields to identify, prevent, and control zoonoses and transboundary animal diseases.
      • Translational Research Platform for Veterinary Biologicals (TRPVB), to allow a collaborative and coordinated approach for the translation of innovations in the domain of veterinary biologicals, vaccines, and diagnostics, the Department of Biotechnology (DBT) and TANUVAS-Chennai have formed a partnership known as TRPVB. The goal of TRPVB is to translate veterinary vaccinations, diagnostics, and other biologicals into use in the field and to use their benefits to raise farmland's economic standing and increase animal health and production.

      Companies Profiled

      • Zeus Biotech Pvt. Ltd.
      • Invetx
      • Ingenta Connect
      • Kingfisher Biotech
      • Animab
      • Boehringer Ingelheim
      • Beveridge & Diamond PC
      • RSPCA
      • Santa Cruz Biotechnology
      • Pfizer

      Report Segmentation:

      By Product

      • Diagnostic Tests
      • Vaccines
      • Drugs
      • Reproductive and Genetic Medications
      • Feed Additives

      By Application

      • Diagnosis of Animal Disease
      • Treatment of Animal Disease
      • Preventive Care of Animals
      • Drug Development
      • Others

      By End Use

      • Laboratories
      • In-house Testing
      • Clinics
      • Others

      By Geography

      • North America
        • United States
        • Canada
        • Mexico
      • South America
        • Brazil
        • Argentina
        • Others
      • Europe
        • United Kingdom
        • Germany
        • France
        • Spain
        • Others
      • Middle East and Africa
        • Saudi Arabia
        • UAE
        • Israel
        • Others
      • Asia Pacific
        • Japan
        • China
        • India
        • South Korea
        • Indonesia
        • Thailand
        • Others

      For more information about this report visit https://www.researchandmarkets.com/r/u3bboq

      About ResearchAndMarkets.com
      ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

      Media Contact:

      Research and Markets
      Laura Wood, Senior Manager
      [email protected] 

      For E.S.T Office Hours Call +1-917-300-0470
      For U.S./CAN Toll Free Call +1-800-526-8630
      For GMT Office Hours Call +353-1-416-8900

      U.S. Fax: 646-607-1907
      Fax (outside U.S.): +353-1-481-1716

      Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

      SOURCE Research and Markets

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.